"Remember the Tasly deal...
Mesoblast will receive double-digit escalating royaltieson net product sales in China. Mesoblast is eligible to receive six escalating milestone payments upon the product candidates reaching certain sales thresholds in China."
A while ago I had a bit of play with numbers, Tasly and China, and the Chinese Yuan. A little later I found out what the average white collar was in Beijing, my price estimate for treatment might have been a little on the low side based on how imported western medicines are priced in China, fairly similar to Japan. To balance that idea the treatment would be made locally by Tasly.
https://hotcopper.com.au/posts/34455651/single
A bit boggling but somewhere to start.
the shorts will bail with margin calling and announcements due, page-392
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.005(0.32%) |
Mkt cap ! $1.798B | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.52 | $6.446M | 4.092M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 62215 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.58 | 14678 | 2 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |